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ABSTRACT (181 words)
Melanoma has a high propensity to metastasize and is often lethal. Effective biomarkers and therapies are lacking, so candidate identification remains a clinical priority. RNA half-life is closely related to its cellular physiological function, and stability determinants may therefore have regulatory functions.
Micro(MI)RNAs have primarily been studied with respect to post-transcriptional mRNA regulation and target degradation. Here we study the impact of tumor suppressive melanoma MIRNA MIR211 on transcriptome stability and phenotype in the A375 amelanotic melanoma cell line. Using 5'-bromouridine IP chase (BRIC)-seq, transcriptome-wide RNA stability profiles revealed highly regulated genes and pathways important in this melanoma cell line. Using a combinatorial approach of BRIC-seq, RNA-seq, and in silico predictions, we identify both existing and novel direct MIR211 targets. DUSP3 is validated as one such novel MIR211 target, which itself sustains colony formation and invasion in A375 cells, probably via MAPK/PI3K signaling. MIRNAs have the capacity to control RNA turnover as a gene expression mechanism. RNA stability profiling is an excellent tool for interrogating functionally relevant cancer pathways and MIRNA targets when combined with other high-throughput and in silico approaches.
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INTRODUCTION
Melanoma is the commonest cause of skin cancer-related deaths, with an estimated 90,000 diagnoses and 10,000 deaths in the US in 2018 (Siegel et al. 2018) . The high mortality associated with melanoma is due to its intrinsic aggressiveness, metastatic potential, and resistance to conventional therapies (Pawlik and Sondak 2003) . There is a pressing need to better understand the abnormal biological processes contributing to melanoma development, metastasis, and resistance to develop new biomarkers and therapies.
Whole transcriptome sequencing (RNA-seq) is now a standard method to interpret the cellular state during disease development and progression. However, RNA-seq represents a static image of the process of transcription, while biological processes are by their very nature dynamic. Recent studies on transcriptome dynamics have shown that transcript stability is correlated with function (Yang et al. 2003; Narsai et al. 2007; Lugowski et al. 2018; Mitra et al. 2018 ). For instance, transcription factor mRNAs have high average decay rates (Yang et al. 2003) , and mRNA turnover correlates with signaling pathways active in cancer, suggesting a post-transcriptional component to oncogenesis (Benjamin and Moroni 2007) . Hence, understanding transcript dynamics is important for understanding disease pathogenesis including in cancer.
mRNA decay studies have traditionally been dominated by the use of transcriptional inhibitors such as actinomycin D (Singer and Penman 1972; Mitra et al. 2018) or α -amanitin (Alkallas et al. 2017; Lugowski et al. 2018 ) to arrest transcription. mRNA concentrations are then quantified at progressive time points after transcriptional arrest. However, these transcriptional inhibitors stress cells and themselves alter transcript localization, stability, and cellular proliferation, introducing unintended and confounding variables (Bensaude 2011; Tani et al. 2012) . More recent metabolic nucleotide labeling techniques such as with 5-bromouridine (Tani et al. 2012; Imamachi et al. 2014) , 4-thiouridine (Tani et al. limitations by providing a direct read-out of transcript decay. Here we exploit the recently described 5'-bromouridine IP chase (BRIC)-seq assay (Tani et al. 2012; Imamachi et al. 2014) , in which the nucleotides of newly synthesized transcripts are labeled with 5-bromouridine (BrU), to study transcriptomic stability in melanoma cells. Coupling BrU labeling with RNA-seq quantifies global RNA (mRNAs and long non-coding (lncRNAs)) stability over time without unduly perturbing the environment (Tani et al. 2012; Imamachi et al. 2014; Imamachi et al. 2017 ).
MicroRNAs (MIRNAs) are a class of single-stranded short noncoding RNA, typically 22 nucleotides long in the mature form (Ha and Kim 2014) . MIRNAs are well known post-transcriptional regulators in both health and disease (Peng and Croce 2016; Alberti and Cochella 2017) . MIRNAs tend to repress gene expression by binding to MIRNA-specific sites in the 3' UTR of the target mRNA in conjugation with the AGO protein-containing RNA-induced silencing complex (RISC) (Kawamata and Tomari 2010) . Altered regulation of MIRNAs or their targets is common in cancers, with MIRNA dysregulation shown to have both oncogenic and tumor suppressive roles (Hayes et al. 2014; Peng and Croce 2016) . Further, MIRNA targets tend to have shorter half-lives (Narsai et al. 2007) , so MIRNA have a direct impact on steady-state transcript levels and ultimately protein activity. Thus, a MIRNA-induced change in transcript stability, for example of oncogenes or tumor suppressor genes, has functional consequences (Benjamin and Moroni
2007; Khabar 2017).
Here we explore the transcriptome stability of the stage IV amelanotic melanoma cell line A375 to better understand its role in melanoma development and progression. We also investigate RNA dynamics in the presence and absence of MIR211, which acts as a tumor suppressor in this cell line (Mazar et al. 2010; Mazar et al. 2016) . We show that MIR211 decreases transcriptome stability. MIR211-dependent destabilization also downregulates several target genes and pathways involved in cancer progression.
Using a combination of stability dynamics, gene expression changes, and in silico prediction; we decipher 
RESULTS AND DISCUSSION
Transcriptomic stability and decay in the A375 amelanotic melanoma cell line
We were motivated to study the transcriptome stability of A375 amelanotic melanoma cells to better understand the relationship between mRNA stability and tumor phenotype. To this end, we used BRICseq to quantify transcriptome-wide stability (Imamachi et al. 2014; Imamachi et al. 2017 ). A375 cells were subjected to BRIC-seq at four timepoints (0, 1, 3, and 6 h) (Fig. 1A) to determine transcript decay rate or half-life. BrU labelled RNA was pulled down using an anti-BrdU antibody before being deep sequenced and processed to obtain read counts normalized to spike-in control RNA (see Methods).
Normalized RNA reads were filtered for quality to obtain the decay profile (Fig. 1B) , which was converted into half-lives (Fig. 1C, Table S1 ).
At the transcriptome-wide level, the majority of transcripts decayed over time (Fig. 1B) . Overall, transcripts had half-lives of under 2 h (mean 1.459 h, median 1.248 h) (Fig. 1C) , with mRNA stability (mean 1.512 h, median 1.324 h) higher than lncRNA stability (mean 1.077 h, median 0.9364 h) but comparable to pseudogene stability (mean 1.564 h, median 1.248 h) (Fig. 1C) . BRIC-seq quantified halflives were validated by BRIC-qPCR for selected candidates, and MYC and GAPDH half-lives were within 20% of the deep sequencing estimate and half-life ratios were comparable (Fig. S1 ).
We next established whether transcript stability was associated with gene function in A375 cells. Gene ontology (GO) analysis showed that the top 5% most stable coding transcripts had a housekeeping
function (e.g., mitochondrial function, metabolic processes, and enzyme binding), while the top 5% most unstable coding transcripts tended to be important for transcription regulation (e.g., nucleic acid binding transcription factor activity, double-stranded DNA binding, negative regulation of gene expression; Fig.   1D ), similar to observed in other genome-wide decay studies using different methodologies (Yang et al. 2003; Narsai et al. 2007; Clark et al. 2012; Tani et al. 2012) . With respect to "hallmark" signatures (Subramanian et al. 2005) , the most stable transcripts were enriched for genes involved in epithelial to mesenchymal transition and MYC signaling in addition to housekeeping metabolic pathways such as oxidative phosphorylation (Fig. 1E) , while unstable transcripts were enriched for signaling pathways that play significant role in melanoma progression such as TNFα (Katerinaki et al. 2003; Gray-Schopfer et al. 2007 ), p53 (Box et al. 2014) , and TGTβ (Busse and Keilholz 2011; Perrot et al. 2013) . Interestingly, unstable genes were enriched for genes downregulated by UV radiation (Giles et al. 2012) and KRAS signaling (Ji et al. 2012; Frederick et al. 2013) , two common drivers of melanoma progression. Overall, many pathways and processes are regulated at the RNA stability level, with the unstable decay profiles identifying highly regulated genes and pathways important in melanoma progression.
MIR211-mediated decay targets coding and non-coding transcripts
To better understand the role of MIRNAs in transcript stability and cancer progression in A375 cells, we next determined transcriptome stability dynamics in A375 cells overexpressing MIR211 (A375/211 cells), a known tumor suppressor ( Fig. 2A, Fig. 2B ) (Mazar et al. 2010; Xu et al. 2012; Mazar et al. 2016 ). MIR211 overexpression reduced the half-lives of all RNA species, especially mRNAs (mean 1.297 h, median 1.170 h, 14% reduction compared to parental cells) and pseudogenes (mean 1.365 h, median
1.187 h, ~13% reduction compared to parental cells; Fig. 2C ). While MIR211 overexpression had little effect on the half-life distribution (Fig. 2C) , the highest stability changes occurred in the most stable A735 transcripts (Fig. 2D) , accounting for the lower mean half-lives for each transcript species.
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GO and hallmark analysis suggested that MIR211 preferentially decreased the half-lives of genes involved in metabolic and energy-generating activities ( Fig 
MIR211 target prediction using BRIC-seq stability data
MIR211 might destabilize transcripts through both direct (MIR211 binding to the 3'UTR of the target mRNA with the RISC complex to degrade mature transcript) or indirect (destabilized through overall changes in the regulatory state of the cell) regulation. The observed level of an individual transcript will be governed by both the degradation rate and the transcription rate.
Given that MIRNAs directly degrade transcript, we reasoned that direct MIR211 targets will have (i) lower stability (i.e., decreased half-lives, =< 80%) in A375/211 cells than in parental A375 cells; (ii) lower expression levels (Fig. 3A) , and (iii) MIR211 target sequences in their 3'UTRs. Using this stringent approach, 16 protein-coding genes ( Fig. 3B and Fig. 3C ) had a high probability of being MIR211 targets, and indeed PDK4 and EFEMP2 have been shown to be direct MIR211 targets in melanoma (Bell et al. 2014; Mazar et al. 2016) . GO analysis of the selected candidates suggested that MIR211 directly targets genes related to cellular metabolism, and several of the predicted MIR211 targets have been implicated in
8 the development and progression of other cancers; for example, ANO5 is downregulated in thyroid cancer (Chang et al. 2017) ; GREB1 is upregulated in ovarian (Hodgkinson et al. 2018) , breast (Ghosh et al. 2000) , and prostate cancers (Rae et al. 2006) ; and EFEMP2 is upregulated in glioma (Wang et al. 2015) and colorectal cancers (Yao et al. 2012) . Some previously predicted MIR211 targets in melanoma cell lines such as RAB22A, SERINC3, AP1S2 (Margue et al. 2013) ; NUAK1 (Bell et al. 2014 );
BRN2/POU3F2 (Boyle et al. 2011) did not meet the criteria, suggesting that the approach shows some cell type specificity. Nevertheless, combining stability data with gene expression data and existing information appears to provide a highly stringent approach for identifying MIRNA targets.
DUSP3 is a MIR211 target in A375 where it promotes cancer progression
To examine whether our approach had successfully identified a hitherto unknown MIR211 target in melanoma, we selected DUSP3 for further validation. DUSP3, also known as vaccinia-H1 related (VHR) (Ishibashi et al. 1992) , has been shown to be functionally involved various cancers including cervical carcinoma (Henkens et al. 2008) , prostate cancer (Arnoldussen et al. 2008) , and breast cancer (Hao and ElShamy 2007) . However, there are no reports of DUSP3 involvement in melanoma or its regulation by MIR211.
We first validated DUSP3 as an MIR211 target. BRIC-qPCR (t 1/2 ; A375= 0.956 h, A375/211=0.775 h) ( Fig. 3E ) and RT-qPCR (Fig. 3F) showed that MIR211 upregulated the DUSP3 transcript decay rate and downregulated DUSP3 expression. There were two in silico-predicted MIR211-binding sites in the DUSP3 3'UTR ( Fig. 3G) , so we tested both sites for MIR211 targeting by transfecting cells with a luciferase vector containing native DUSP3 3'UTR or mutated (mut) DUSP3 3'UTR (Fig. 3G) . The mutated 3'UTR abrogated MIR211-dependent downregulation of luciferase activity (Fig. 3H ) compared to the native 3'UTR.
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To understand whether MIR211-mediated DUSP3 downregulation in melanoma was functional, we next performed loss-of-function experiments with siRNA knock-down of endogenous DUSP3 in A375 cells (Fig. 4A) . While MIR211 overexpression significantly reduced proliferation compared to parental A375 cells (Fig. 4B) , siRNA knockdown of DUSP3 in A375 cells did not affect proliferation (Fig. 4B) .
However, DUSP3 knockdown reduced invasion and colony formation at comparable levels to those observed in A375/211 cells compared to A375 (Fig. 4C, Fig. 4D ), suggesting that DUSP3 downregulation might contribute to MIR211-dependent regulation of cell invasion and anchorageindependent growth. DUSP3 has previously been shown to induce cell growth and inhibit apoptosis in adenocarcinoma cells (Arnoldussen et al. 2008) , and DUSP3 depletion in HeLa cells induces cell cycle arrest and reduces cell proliferation (Rahmouni et al. 2006) . Furthermore, DUSP3 knockout reduces cell migration (Chen et al. 2017 ) and inhibits in vitro angiogenic sprouting (Amand et al. 2014) , consistent with the oncogenic function seen here.
DUSP3 is a dual activity phosphatase that regulates signaling pathways by dephosphorylating target tyrosine and/or serine/threonine residues (Huang and Tan 2012) . While DUSP3 has been shown to specifically target ERK1/2 and JNK MAP kinase (MAPK) pathways (Rahmouni et al. 2006; Hao and ElShamy 2007; Amand et al. 2014; Tambe et al. 2016) in multiple cancers, its role in melanoma is unknown. To investigate the specific kinase pathway(s) regulated by DUSP3 in A375, we assessed phosphorylation of various MAPK pathway members using a MAPK array upon DUSP3 knockdown (Fig. 4E) . DUSP3 knockdown increased phosphorylation of pAKT, pERK1, pHSP27, p70 S6kinase, and pmTOR, similar to the pattern seen in A375/211 cells (Fig. 4F) . While previous reports have suggested DUSP3 targets the ERK pathway, our observation suggests that DUSP3 also regulates PI3K/AKT signaling, not only upstream at the level of pAKT but also the downstream pathways members p70
S6kinase and pmTOR ( Fig. 4G ) (Hemmings and Restuccia 2012) . Recent reports have suggested that HSP27 is associated with both the ERK and AKT pathways, suggesting the observed change in phosphorylation could be via these pathways (Rane et al. 2003; Robitaille et al. 2010; Deng et al. 2016 ). 
CONCLUSIONS
Here we show that transcript stability is an important contributor to the cancer phenotype and that miRNAs have a global impact on transcript stability that might affect the cancer phenotype. We exploited a genome-wide transcript stability assay to identify context-dependent transcriptome-wide miRNA targets. Our combinatorial approach of using stability, differential expression, and in silico prediction proved to be a stringent method to identify functionally relevant and novel MIRNA targets. We show that the novel direct MIR211 target DUSP3 has an oncogenic role in A375 melanoma cells. Finally, our results support the role of MIR211-dependent regulation of DUSP3 in regulating melanoma growth and progression by modulating MAPK/PI3K signaling.
Materials and methods

Cell culture
The human stage IV amelanotic melanoma cell line A375 (ATCC Number: CRL-1619) and the derived 
BRIC-Seq and BRIC-qPCR
A375 and A375/211 cells were incubated with metabolic bromouridine (BrU) for 24 h and then used as per the BRIC kit (RN1007/1008; MBL International, Woburn, MA) protocol. Briefly, labeled medium was replaced with fresh medium and cells were collected at 0, 1, 3, and 6 h post labeling. Total RNA was 
RNA extraction, cDNA synthesis, and qPCR
Total RNA was isolated from cells using the Direct-zol RNA miniprep kit (R2060, Zymoresearch), with subsequent quantification using Nanodrop (Thermofisher). TaqMan probes were used to quantify DUSP3 (Hs01115776_m1) using GAPD (Hs99999905_m1) and ACTB (Hs1060665_g1) as control. Standard qPCR primers were used for GAPDH, MYC and BRIC-spike in control for BRIC-qPCR. Fold change was obtained from Ct value comparison. Fold change from different condition was compared using two-tailed Student's t-test assuming equal variance.
RNA-seq
RNA sequencing was done at the Genomics Core at the Sanford Burnham Prebys, Orlando, FL. Before sequencing, total RNA quality was assessed with the Agilent Bioanalyzer Nano Assay (Part no. 5067- The reads were mapped to GRCh38/hg38 human genome assembly p12 (release 28, www.gencodegenes.org) using HISAT2 and annotated using corresponding release version gencode
1512) (Agilent Technologies
1 2 comprehensive annotation file. Mapped reads were quantified using StringTie to obtain FPKM values, which were converted to read counts using prepDE.py script (provided in StringTie manual).
For differential gene expression analysis reads count from two independent samples for A375 and A375/211 each were analyzed by DESeq2 script in R (Love et al. 2014 ).
Decay rate analysis
For BRIC-seq decay analysis, read counts from 4 time points (0, 1, 3 and 6 h) were normalized to that of spike-in RNA counts to obtain normalized read counts. Normalized read counts at time 1/3/6 h were For BRIC-qPCR decay analysis, fold change of genes were obtained with respect spike-in RNA at each time point. Fold change at time points 1/3/6 h were then scaled to that at 0 h and fitted on to a exponential curve to obtain decay constant that was converted to half-life as described above.
GSEA and Gene Ontology (GO) analysis
Genes selected for GO term and hallmark analysis were subjected to functional annotation on GSEA webbased application (broad.mit.edu/gsea/) (Subramanian et al. 2005) . GSEA enrichment analysis for decay ratio was conducted with GSEAPreranked list with rank determined by decay rate ratio between A375 vs A375/211.
Target cleavage assays
The 3′ UTR sequences of DUSP3 (NM004090) mRNA genes were amplified by PCR using the primers (forward: AGTGGCAGGGCGGCCGCCACTGCCGGGAAGGTTATAGC, reverse:
1 3 GGTGATGATGACCGGTAGCGAGTCCAATTGCTTCATGTG ) using A375 genomic DNA. The forward and reverse primer contained 5′ NotI or 3′ AgeI (underscored sequence), respectively. The PCR product was cloned into pcDNA6/luc/NP3 into a NotI-AgeI site using the Clontech In-Fusion kit (Clontech Laboratories, Mountain View, CA). To remove the two putative MIR211 sites, mutated DUSP3 3'UTR was engineering via site-directed mutagenesis using the primers: first site (XhoI site) CACCAACATTCTCGAGCCAAACCATCCATCACCATG, reverse:
GATGGTTTGGCTCGAGAATGTTGGTGCCTTTTGTGCC; second site (AvrII site), forward:
TGGTAGCTCTCCTAGGTCTGTCCAGAAAAATTCACTC, reverse:
TCTGGACAGACCTAGGAGAGCTACCAAATTGTTT. The mutated insert was cloned into the same insertion site of a luciferase vector. HEK293T cells were transfected with DUSP3 3'UTR or mutated 3'UTR(DUSP3mut) with and without MIR211 overexpression construct (as described in (Sahoo et al.
2019)). After 48 h incubation, cells were washed in PBS and lysed using cell lysis buffer (Promega,
Madison, WI). The lysate was quantified for firefly and renilla luciferase activity using Dual-Glo
Luciferase assay system (Promega) to determine MIR211-dependent target instability.
DUSP3 siRNA knockout
A375 cells were transfected with siRNA against DUSP3 (siDUSP3) mRNA (s4371, Ambion) to achieve downregulation of DUSP3 expression. Negative control siRNA (siNEG) (AM4635, Ambion) was used as a control for the assay.
Cell proliferation assay
Cells were plated in triplicate at 5000 cells per well into 96-well plates for the various time points indicated in the figures and legends. Cell proliferation was assessed using the CellTiter96 Aqueous One Solution Cell Proliferation Assay (MTS) kit (Promega, Madison, WI).
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Cell invasion assay
Cell invasion assay was performed using Corning BioCoat Matrigel Invasion Chambers (Discovery Labware, Bedford, MA) according to the manufacturer's protocol. Briefly, cells were starved in FBS-free medium for 24 h before being transferred into the upper chambers in serum-free medium (50,000 cells per chamber). Medium containing 10% FBS was added to the lower chambers. Cells were incubated for 48 h at 37ºC. To quantify cell invasion, migrated cells were stained with 0.5% crystal violet dye. Excess staining was removed by rinsing with water and subsequently membrane was dried before taking images.
Dye from stained cells was extracted using methanol, and optical density was measured at 570 nm on a spectrophotometer to quantify cell invasion intensity.
Western blotting and MAPK phosphoarray
Whole cell extracts from A375 cell, A375 cells transfected with siNEG or siDUSP3 and A375/211 cells were fractionated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane using a transfer apparatus according to the manufacturer's protocols (Bio-Rad). After incubation with blocking buffer containing 5% BSA in TBST (10 mM Tris, pH 8.0, 150 mM NaCl, 0.5% Tween 20) for 60 min, the membrane was washed once with TBST and incubated with antibodies against DUSP3 (4752, Cell Signaling), and β -Actin (4967, Cell Signaling) diluted in blocking buffer at 4 °C for 16 h. Membranes were washed three times for 10 min and incubated with a 1:3000 dilution of horseradish peroxidaseconjugated anti-mouse or anti-rabbit antibodies for 2 h. Blots were washed with TBST three times and developed with the ECL system (Amersham Biosciences) according to the manufacturer's protocols.
To determine the phosphorylation level of various MAPK pathway members, the phospho-MAPK array assay was done using Human phospho-MAPK array kit (R&D systems) according to the provided protocol. 
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